Skip to main content
. Author manuscript; available in PMC: 2018 Jan 30.
Published in final edited form as: J Hypertens. 2016 Nov;34(11):2172–2179. doi: 10.1097/HJH.0000000000001070

Table 3. Hazard Ratios (HRs) for factors associated with drop-out after clinical assessment and adjusted Odds Ratios (aHRs) for both sites.

Diabetes (+/− hypertension) Hypertension BP not raised on repeat measurement at clinic Overall drop-out

HR (95% CI) HR (95% CI) HR (95% CI) aHR (95% CI) p-value
Diagnosis
Diabetes 1 -
BP medication 1.08 (0.91-1.28) 0.374
BP no medication 1.65 (1.38-1.98) <0.001
Site
Lilongwe 1 1 1 1 -
Karonga 0.72 (0.53-0.99) 0.77 (0.68-0.87) 0.72 (0.60-0.87) 0.76 (0.68-0.84) <0.001
Sex
Male 1 1 1 1 -
Female 1.11 (0.80-1.54) 0.80 (0.70-0.91) 0.79 (0.65-0.95) 0.92 (0.83-1.01) 0.092
Age group
< 25 0.87 (0.21-3.55) 1.85 (1.30-2.62) 1.05 (0.72-1.53) 1.19 (0.92-1.53) 0.182
25 to 45 1 1 1 1 -
45 to 65 0.55 (0.39-0.78) 0.67 (0.57-0.79) 0.66 (0.53-0.81) 0.74 (0.65-0.84) <0.001
65+ 0.44 (0.28-0.69) 0.60 (0.50-0.71) 0.49 (0.38-0.65) 0.69 (0.60-0.80) <0.001
Prior HT/Diabetes meds
Yes 0.49 (0.36-0.67) 0.53 (0.46-0.61) 0.36 (0.28-0.45) 0.49 (0.43-0.55) <0.001
No 1 1 1 1 -
BMI (kg/m2)
Below 18 2.20 (0.79-6.10) 1.01 (0.75-1.37) 1.03 (0.66-1.61)
18 to 25 1 1 1
25 to 30 1.03 (0.71-1.50) 0.84 (0.72-0.97) 1.03 (0.83-1.28)
Above 30 0.80 (0.54-1.18) 0.87 (0.73-1.04) 0.82 (0.63-1.07)
Paid employment
Yes 1 1 1
No 0.85 (0.57-1.29) 0.75 (0.62-0.91) 0.82 (0.63-1.08)